A prospective cohort study of ultra-rush subcutaneous immunotherapy in dust mite-induced allergic rhinitis
UR-SCIT achieves therapeutic efficacy comparable to Cluster SCIT, with both demonstrating robust symptom control and favorable immunological changes. The similar safety profiles, with no serious adverse events indicate that UR-SCIT is a viable new option for AIT in clinical practice.
Authors
- Jieqing Yu (ORCID: https://orcid.org/0000-0002-8355-7335)
- Hao Peng
- Zhiqun Huang
- Jing Ye
- Li Shen
- Yishan Xiong
- Wenqi Luo
Institutions
- Nanchang University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Jiangxi Academy of Environmental Sciences (CN)
- Jiangxi Academy of Sciences (CN)
- First Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- World Allergy Organization Journal
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.waojou.2026.101334
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 0.00